NOVO NORDISK A/S: Financial statements 2016
CVR: 24256790
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
NOVO NORDISK A/S (CVR 24256790) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 111,780,000,000 and a net result of DKK 37,925,000,000 compared with DKK 34,860,000,000 the year before. That is an increase of 3.6% compared with the year before. The profit margin was 33.9%. Equity in the 2016 report amounted to DKK 45,269,000,000. The solvency ratio was 46.4%.
- Revenue
- DKK 111,780,000,000
- Gross Profit
- DKK 94,597,000,000
- Profit/Loss
- DKK 37,925,000,000
- Equity
- DKK 45,269,000,000
- Total Assets
- DKK 97,539,000,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 111.8B | 94.6B | 37.9B | 45.3B | - |
| 2015 | 107.9B | 91.7B | 34.9B | 47B | - |
| 2014 | 88.8B | 74.2B | 26.5B | 40.3B | - |
Official annual report
Find more companies like NOVO NORDISK A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
As of December 31, 2016, Lars Rebien Sørensen has stepped down as adm. dir. of NOVO NORDISK A/S.
As of December 31, 2016, Lars Fruergaard Jørgensen has stepped down as director of NOVO NORDISK A/S.
As of September 1, 2016, Henrik Ehlers Wulff is registered as director of NOVO NORDISK A/S.
As of September 1, 2016, Jakob Riis has stepped down as director of NOVO NORDISK A/S.
NOVO NORDISK A/S has published its annual report for 2015. Revenue came to DKK 107,927,000,000, and the net result was DKK 34,860,000,000.
As of March 18, 2016, Brian Fredrick Daniels has joined the board of directors of NOVO NORDISK A/S.
As of March 18, 2016, Eivind Drachmann Kolding has left the board of directors of NOVO NORDISK A/S.
As of March 18, 2016, Thomas Paul Koestler has left the board of directors of NOVO NORDISK A/S.
About NOVO NORDISK A/S
NOVO NORDISK A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1931. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named NOVO-NORDISK A/S and NOVO INDUSTRI A/S. The management consists of Maziar Doustdar and Karsten Munk Knudsen. The board consists of Lars Rebien Sørensen (chair), Cornelis de Jong, Britt Meelby Jensen and Désireé Jantzen Asgreen. The company is owned by Novo Holdings A/S. The company has 27,151 employees (2026). In 2025, the company reported revenue of DKK 309,064,000,000 and a net result of DKK 102,434,000,000 compared with DKK 100,988,000,000 the year before. Equity in the 2025 report amounted to DKK 194,047,000,000.